Status:

ACTIVE_NOT_RECRUITING

MR Elastography in Intracranial Lesions: Feasibility & Accuracy

Lead Sponsor:

Shengjing Hospital

Conditions:

Brain Neoplasms

Eligibility:

All Genders

8-83 years

Brief Summary

Brain tumors, despite their relatively low incidence among cancers, are associated with high morbidity and mortality due to the brain's complexity. Biopsy, the gold standard for tumor grading, is limi...

Detailed Description

Despite their relatively low incidence among all cancers, brain tumors are associated with substantial morbidity and mortality, attributed to the brain's intricate structure and critical physiological...

Eligibility Criteria

Inclusion

  • All patients undergoing intracranial space-occupying lesions resection surgery are eligible for inclusion in the study.

Exclusion

  • Patients with metallic implants or foreign bodies in their bodies (pacemakers, artificial metallic heart valves, metal joints, metal implants, and those who can not remove dentures, insulin pumps, or contraceptive rings)
  • Pregnant women in the first trimester (within three months)
  • Patients with severe claustrophobia or anxiety
  • Patients with severe fever
  • Patients who can not tolerate MRE
  • Patients with vascular malformations and aneurysms.
  • Patients who do not sign an informed consent

Key Trial Info

Start Date :

May 9 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 9 2025

Estimated Enrollment :

512 Patients enrolled

Trial Details

Trial ID

NCT06916715

Start Date

May 9 2017

End Date

December 9 2025

Last Update

April 13 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Shengjing Hospital

Shenyang, Liaoning, China, 110000